24.55MMarket Cap-792P/E (TTM)
3.6500High3.4500Low23.05KVolume3.6500Open3.6500Pre Close81.48KTurnover0.42%Turnover RatioLossP/E (Static)6.99MShares13.490052wk High-0.67P/B19.07MFloat Cap2.260052wk Low--Dividend TTM5.43MShs Float126.7200Historical High--Div YieldTTM5.48%Amplitude1.2600Historical Low3.5340Avg Price1Lot Size
Minerva Neurosciences Stock Forum
$Infobird Software(IFBD.US)$ $Ascent Solar Technologies(ASTI.US)$ $Rail Vision(RVSN.US)$ $J-Long Group(JL.US)$ $Minerva Neurosciences(NERV.US)$
📊⚡️📊
Roluperidone NDA receives CRL from FDA 🙁
⚠️ FDA cited clinical deficiencies:
▪️ Insufficient substantial evidence of effectiveness
▪️ lacks data on concomitant antipsychotic admin.
▪️ lacks data to establish change in negative symptoms of schizophrenia
▪️ inadequate number of subjects exposed at proposed dose
ℹ️Add'l info on Roluperidone…
⇒ for negative symptoms of schizophrenia
⇒ NDA
⇒ PDUFA: 02/26/24
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
No comment yet